Kinetics of anti-SARS-CoV-2 antibody titer in healthy adults up to 6 months after BNT162b2 vaccination measured by two immunoassays: A prospective cohort study in Japan

BACKGROUND: Although several assays are used to measure anti-receptor-binding domain (RBD) antibodies induced after severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccination, the assays are not fully comparable in practice. This study evaluated the immunogenicity of the BNT162b2 mRNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuura, Tomoka, Fukushima, Wakaba, Nakagama, Yu, Kido, Yasutoshi, Kase, Tetsuo, Kondo, Kyoko, Kaku, Natsuko, Matsumoto, Kazuhiro, Suita, Asae, Komiya, Eriko, Mukai, Emiko, Nitahara, Yuko, Konishi, Ayako, Kasamatsu, Ayane, Nakagami-Yamaguchi, Etsuko, Ohfuji, Satoko, Kaneko, Yukihiro, Kaneko, Akira, Kakeya, Hiroshi, Hirota, Yoshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376311/
https://www.ncbi.nlm.nih.gov/pubmed/36028457
http://dx.doi.org/10.1016/j.vaccine.2022.08.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376311/
https://www.ncbi.nlm.nih.gov/pubmed/36028457
http://dx.doi.org/10.1016/j.vaccine.2022.08.018

Ejemplares similares